Commercials from prescription drugs by Big Pharma copmanies have become a regular part of the American television experience.

The one newcomer on the list was UCB’s Bimzelx, which knocked Intra-Cellular Therapies' Caplyta out of the running as it took ninth place. UCB shelled out $10.3 million to air five commercials for the ...

Tremfya is back on top, securing the No. 1 spot for TV pharma brand ad impressions in August. The Johnson and Johnson brand achieved an impressions SOV of 5.18%, securing 2.9 billion impressions with ...

Chevrolet's "The Heartbeat of America" performed in the 90th percentile for likeability and the 86th percentile for desire, ...

Swoop and iSpot have joined forces to deliver insights into cross-platform ad exposures against specific audiences for healthcare and pharma marketers. Through the newly announced partnership, ...